Why are dampness, condensation, and mould still persistent issues, and will Awaab’s Law contribute to creating healthier homes? David Bly of Cornerstone Management Services Limited provides the answer.
Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?
Secarna Pharmaceuticals, the next-generation antisense drug discovery and development company, is developing novel approaches to successfully target Neuropilin 1 (NRP1), a promising target for the treatment of cancer.
It’s not too late to respond to the challenges of the climate emergency – but only if we fast-track vital engineering skills into our economy before 2030 – The Royal Academy of Engineering explains.
Dr. Stefan Rehm, Managing Director of Hypion GmbH, presents the logic of integrated hydrogen hubs as concept to decarbonise heavy duty road transportation.
Amp X is an innovative digital energy platform using a unique, whole-system approach to address critical issues that exist in the electricity grid as a result of the ongoing energy transition towards a fully decarbonised future.
Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.
Suzanne Wait and Catherine Whicher from The Health Policy Partnership discuss the opportunities to improve populations’ wellbeing and access to care by harnessing innovative digital health tools and technologies.
